Objective : We recently reported that doxorubicin (Dox), an effective anti-cancer drug, induces apoptosis in cardiac myocytes in association with reduction of Bcl-xl expression. In the present study, we further examined whether overexpression of Bcl-xl ameliorates Dox-induced cardiac myocyte damage. Methods and results: Overexpression of the Bcl-xl gene by adenovirus vector resulted in an 11-fold increase in Bcl-xl protein in neonatal rat cardiac myocytes (BCL) compared to that in cells with b-galactosidase gene transfection (CTL). Although Dox treatment generated similar amounts of reactive oxygen species (ROS) in BCL and CTL, cell viability was maintained and the number of apoptotic cardiac myocytes was significantly decreased in BCL. Cytochrome c release and enhanced caspase-3 activity after Dox treatment were significantly suppressed and Bax expression level was decreased in BCL. Cardiac-specific 21 gene expression is known to be inhibited by Dox. The expression of cardiac a-actin and sarcoplasmic reticulum Ca -ATPase 2a mRNA was equally inhibited in BCL and CTL after Dox treatment. Conclusions: Overexpression of Bcl-xl in cardiac myocytes failed to regulate Dox-induced ROS generation and cardiac-specific gene downregulation but inhibited apoptosis accompanied by reduction of Bax protein.
Introduction
drug, had a protective effect against Dox-induced cardiomyopathy [1] . In addition, mouse with cardiac-specific Doxorubicin (Dox), a clinically effective anti-cancer overexpression of the gene for metallothionein, a drug, has beneficial effects in treating a variety of soft and scavenger of free radicals, was resistant to the cardiac solid human malignancies, but its use is restricted because toxicity induced by Dox [3] . Transgenic mice with cardiacof cardiac toxicity that finally leads to heart failure [1] . The specific overexpression of the signal transducer and acmechanism of Dox-mediated cardiac toxicity involves the tivator of transcription 3 (STAT3) gene, a transcription generation of reactive oxygen species (ROS), which factor downstream of several cytokines including the damage cell membranes, and the selective inhibition of interleukin (IL)-6 cytokine family, was also tolerant cardiac-specific gene expression, such as the cardiac aagainst Dox, in association with inhibition of cardiac- 21 actin, sarcoplasmic reticulum Ca -ATPase2a (SERCA2a) contractile protein gene downregulation and production of and cardiac troponin-I genes [2] . Siveski-Iliskovic et al.
cardiac-protective factors [4] . reported that probucol, a clinically available anti-oxidant
We recently reported that leukemia inhibitory factor, a member of the IL-6 cytokine family, protected cardiac myocytes from Dox-mediated apoptosis by activation of *Corresponding author. Tel.: 181-6-6879-3835; fax: 181-6-6879-the phosphatidylinositol 3-kinase pathway and inhibition of 3839 .
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Time for primary review 32 days.
Bcl-xl reduction [5] . The level of Bcl-xl expression 2.3. TUNEL assay strongly correlates with reduction of the response rate in myeloma cells against chemotherapeutic drugs including
In situ labeling of fragmented DNA was performed with Dox [6] . On the other hand, overexpression of Bcl-2 in a the MEBSTAIN Apoptosis Kit Direct (MBL) as described human ovarian carcinoma cell line conferred a trend previously [5] . In brief, cardiac myocytes were grown on toward sensitivity but not resistance to anti-cancer drug fibronectin-coated glass slides, fixed with 4% paraformal- [7] . In HL-60 cells overexpressing both Bcl-2 and Bcl-xl, dehyde in phosphate-buffered saline (PBS) for 20 min, and downregulation of only Bcl-2 by antisense oligodeoxypermeabilized with 0.2% Triton X-100 for 5 min. The cells nucleotide (ODN) increased sensitivity to cytosine arabiwere first incubated with anti-a-actinin antibody at 378C noside despite Bcl-xl overexpression [8] . These results for 1 h and subsequently with anti-mouse IgG TRITCindicate that the anti-apoptotic effect of Bcl-2 family labeled antibody for 1 h. Thereafter, 50 ml terminal members is cell-specific. Therefore, in the present study, deoxynucleotidyl transferase (TdT)-mediated dUTP nick we examined whether overexpression of Bcl-xl protein end-labeling (TUNEL) reaction mixture containing both protects cardiac myocytes from Dox-induced cell damage, TdT and FITC-dUTP was added to each sample for 1 h at and we attempted to clarify the molecular mechanism of 378C. The cells were analyzed by fluorescence microscopy. Bcl-xl-mediated cardiac myocyte protection.
Numbers of TUNEL-positive cells counted in a-actininpositive cardiac myocytes (n5500) are expressed as percentages.
Methods

Measurement of cell viability (MTS assay)
4
All experiments were performed in accordance with Cardiac myocytes were cultured at a density of 1?10 / Guidelines for Animal Experiments of Osaka University 100 ml in 96-well dishes, and were infected with adenoGraduate School of Medicine.
virus carrying the Bcl-xl gene (BCL) or the b-galactosidase gene (CTL) after 2 days. The cells were stimulated with Dox for 18 h and their viability was examined by 2.1. Reagents and cell culture MTS h3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner saltj cell Neonatal rat cardiac myocytes were isolated from 1-or respiratory assay (Promega, Madison, WI, USA) according 2-day-old Wistar rats (Kiwa Jikken Dobutsu, Wakayama, to the manufacturer's instructions. Viability was expressed Japan) as previously described [9] . Dox was obtained from as the absorbance at 490 nm measured with a specKyowa Hakko (Tokyo, Japan). Anti-Bax and Bcl-xl antitrophotometer. bodies were purchased from Santa-Cruz Biotechnology (CA, USA) and anti-a-tubulin and a-actinin antibodies 2.5. Measurement of creatine phosphokinase (CPK) from Sigma (MO, USA). Human Bcl-xl cDNA was kindly provided by Dr. S. Nagata, SERCA2a cDNA by Dr. M.
Determination of CPK in cultured conditioned medium Tada [10] (Osaka University, Japan) and cardiac a-actin was performed using a commercially available kit cDNA by Dr. H. Ito [2] (Tokyo Medical and Dental (MERCK-1-TEST CK, Kanto Kagaku, Tokyo, Japan). University, Japan). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA was purchased from Cayman 2.6. Measurement of ROS (NY, USA).
Cardiac myocytes were incubated with 10 mM dichlorodihydrofluorescein diacetate (DCHF / DA, Nakarai, 2.2. Generation of recombinant adenovirus and Osaka, Japan) for 30 min at 378C in the dark, washed with adenovirus infection PBS and detached with 0.25% trypsin and 0.05% EDTA. Then cardiac myocytes were rinsed three times with PBS Recombinant replication-defective adenovirus carrying containing 5% NCS to remove trypsin and filtered through the Bcl-xl gene or the b-galactosidase gene was prepared 35-mm nylon mesh. They were analyzed immediately and purified as described previously [11] . Two days after using a Becton-Dickinson FACScan with excitation at 488 plating, cardiac myocytes were infected with adenovirus nm and emission at 510 nm. diluted in D-MEM (Gibco BRL, NY, USA) with 5% fetal calf serum (FCS) at 1 to 30 multiplicity of infection (moi).
2.7. Measurement of cytochrome c release Thereafter, viral suspension was removed and cells were cultured for an additional 2 days with medium 199 (MCytochrome c (cyt-c) release into cytosol was examined 199, Gibco BRL) containing 10% newborn calf serum as previously described [12] . In brief, cardiac myocytes (NCS).
were washed with ice-cold PBS and resuspended in 100 ml of extraction buffer containing 50 mM PIPES-KOH (pH TX, USA). Total RNA was separated on 1% formalde-7.4), 220 mM mannitol, 68 mM sucrose, 5 mM EGTA, 2 hyde-agarose gel and transferred to nylon membrane. mM MgCl , 1 mM DTT and proteinase inhibitors for 30 Prehybridization was performed at 428C for 6 h, followed 2 min. Cells were homogenized by passage through a 25-by hybridization for 12 h. The membranes were washed gauge needle for 10 strokes, and the lysates were centhree times with 23SSC and 0.1% SDS at 608C and the trifuged at 750 g for 10 min to pellet out the nuclei. The blots were exposed to X-ray film. remaining supernatants were centrifuged for 15 min at 10 000 g to remove mitochondria (mitochondrial fraction). This supernatant was considered a cytosolic fraction.
2.11. Statistical analysis Western blot analysis of control cardiac myocytes showed that the mitochondrial fraction contained much cyt-c and All values are expressed as mean6S.E.M. Statistical manganase-superoxide dismutase (Mn-SOD) protein but analysis was performed with Student's t-test (Statview). that the cytosolic fraction contained neither cyt-c nor Values of p,0.05 were considered significant. Mn-SOD (data not shown).
Measurement of caspase-3 activity
Results
The activity of caspase-3 was determined with a 3.1. Overexpression of Bcl-xl presents tolerance against Caspase-3 Assay Kit (MBL, Nagoya, Japan). Cardiac Dox in cardiac myocytes myocytes were lysed in buffer containing 10 mM TrisHCl (pH 8.0), 0.32 mM sucrose, 5 mM EDTA, 1 mM
We first examined whether Bcl-xl overexpression supphenylmethylsulfonyl fluoride (PMSF), 1 mM sodium presses Dox-induced apoptosis in cardiac myocytes. after Dox treatment accounted for 38% of CTL and 5% of mM NaCl, 10 mM DTT, 1 mM EDTA, 0.1% 3-BCL ( p,0.05 vs. CTL).
The effect of Bcl-xl overexpression on Dox-induced HAPS) and 10% glycerol at 378C for 1 h. The activity was cardiac myocyte damage was also evaluated by MTS assay assessed with a spectrophotometer at 405 nm.
and CPK release. Viability of CTL decreased after 18 h of Dox treatment in a dose-dependent manner, but BCL 2.9. Western blot analysis significantly maintained viability after 0.5 and 1.0 mM of Dox ( p,0.05 vs. CTL) (Fig. 1C) . CPK concentration in The samples were separated in 15% sodium dodecyl cultured medium increased significantly after 0.5 and 1.0 sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) mM Dox treatment in CTL, but significantly suppressed in gel and resolved proteins were electrophoretically trans-BCL ( p,0.05 vs. CTL) (Fig. 1D) . These findings indicate ferred onto an Immobilon-P membrane (Millipore, MA, that overexpression of Bcl-xl protects cardiac myocytes USA). Membranes were blocked with 5% skim milk and from Dox-induced cell injury. probed with rabbit anti-Bcl-xl, Bax or a-tubulin antibody at 1:1000 dilution for 1 h to detect each protein. They were then incubated with peroxidase-conjugated anti-rabbit IgG 3.2. Dox-induced ROS generation is not suppressed in for an additional 1 h. The immune complexes were cardiac myocytes with Bcl-xl overexpression visualized with Kodak X-OMAT-AR film with an enhanced chemiluminescence system. Dox is known to induce ROS in several kinds of cells, and ROS induction is one of the important mechanisms of 2.10. Northern blot analysis cell injury [13] . We next examined whether Bcl-xl suppresses ROS production induced by Dox. ROS was equally Total RNA was isolated by ISOGEN (Nippon Gene, produced in BCL and CTL after 10 mM Dox treatment Tokyo, Japan) according to the manufacturer's instructions. (Fig. 2a, c) . Augmented ROS generation was also detected Cardiac a-actin and SERCA2a cDNAs were labeled with in these cells cultured without serum (Fig. 2b, d ). These 32 an [a-P]dCTP using PRIME IT labeling kit (Stratagene, results indicate that Bcl-xl failed to scavenge ROS induced by 10 mM of Dox or serum deprivation in cardiac in CTL, but was inhibited in BCL (Fig. 3A) . Caspase-3 myocytes.
also functions as an executor of apoptosis [15] , and inhibition of this enzyme suppresses induction of apop-3.3. Cyt-c release and caspase-3 activation after Dox tosis. Caspase-3 activity increases in CTL after 3 h of Dox treatment are significantly suppressed in cardiac treatment and this increased activity continued up to 12 h myocytes with Bcl-xl overexpression (Fig. 3B) . On the other hand, caspase-3 activity in BCL increased after 6 h of Dox treatment but returned to control Release of cyt-c from mitochondria to cytosol is a key level after 12 h. Caspase-3 activity after Dox treatment was step in the execution of the cell death pathway [14] . Cyt-c significantly lower in BCL than CTL at all time points release was observed with 0.5 and 1.0 mM Dox treatment examined ( p,0.05). Overexpression of Bcl-xl significant-
Discussion
Several studies have demonstrated that apoptosis occurs in murine hearts treated with Dox. Apoptosis is observed in rat heart exposed to 2.5 mg / kg intraperitoneal administration of Dox, with a peak at 24-48 h and return to baseline level within a week [16] . Kang et al. reported that apoptosis occurred in the heart 4 days after Dox injection at a single dose of 15 mg / kg [17] . These findings do not show that prolonged toxicity to myofibrils is responsible for the late cardiomyopathy observed in patients with Dox treatment. On the other hands, Nakamura et al. reported that apoptosis increased in the heart as early as 9 weeks with once a week intravenous administration of 2 mg / kg of Dox for 8 weeks [18] . They demonstrated that neutralization of Fas ligand inhibited Dox-induced apoptosis and that apoptosis increased with deterioration of morphological findings and cardiac function. The period during which years [19] . These results suggest that apoptosis may be an important underlying mechanism of cardiac myocyte loss ly suppressed cyt-c release and subsequent activation of and cardiac dysfunction in patients undergoing Dox treatcaspase-3 in cardiac myocytes after Dox treatment.
ment.
Cardiac myocytes with overexpression of Bcl-xl were 3.4. Bax expression is decreased in cardiac myocytes
evaluated by expression of Bcl-2 family proteins, TUNEL with Bcl-xl overexpression assay, and for caspase-3 activity and phosphorylation of kinases, such as Akt, mitogen activated protein kinase To examine the molecular mechanism of Bcl-xl-me-(MAPK), p38-MAPK and JNK, by Western blot analysis. diated tolerance to Dox, we examined expression level of Regarding expression of Bcl-2 family proteins, Bcl-2 and Bcl-2 protein family members in cardiac myocytes. SurBad expressions were not altered but Bax expression was prisingly, prior to exposure to Dox, cardiac myocytes significantly decreased in BCL than in CTL. Other results overexpressing Bcl-xl demonstrated reduced expression of were the same for BCL and CTL (data not shown). Bax protein, and the level of this expression was inversely Increase in Bcl-xl protein had a protective effect against correlated with that of Bcl-xl (Fig. 4) . The level of Bax Dox-induced cell damage associated with Bcl-2 expresprotein expression in cardiac myocytes with Bcl-xl oversion. The mechanism of Bcl-xl-mediated suppression of expression continued to be reduced even after Dox treatcell damage has been described in several reports [20] [21] [22] . ment (data not shown). The expression levels of Bcl-2 Bcl-xl and Bax change mitochondrial membrane perprotein and Bad protein were not changed in these cells meability, causing cyt-c release mediated by outer memwith either Dox treatment or normal conditions (data not brane transition pores including voltage-dependent anion shown). channels (VDAC) [23] . Shimizu et al. reported that Bax and Bak accelerate opening of VDAC, whereas Bcl-xl 3.5. Downregulation of cardiac-specific gene by Dox closes this channel by direct binding [24] . Bax and Bak treatment thus allow cyt-c to pass through VDAC, but this passage is prevented by Bcl-xl. Activated caspase-9 subsequently The expressions of cardiac a-actin and SERCA2a
cleaves downstream caspase-3 [25] . Our results showed mRNAs after Dox treatment were examined in CTL and that Bcl-xl inhibited cyt-c release from mitochondria, BCL by Northern blot analysis (Fig. 5) . Expressions of subsequent activation of caspase-3 and DNA fragmentation cardiac a-actin and SERCA2a mRNAs were equally in cardiac myocytes. decreased in BCL after 1.0 mM Dox treatment, without Dox is known to produce ROS including oxygen affecting the expression of a housekeeping gene; GAPDH. radicals and hydrogen peroxide, which is a partially Overexpression of Bcl-xl in cardiac myocytes failed to reduced form of oxygen, and to cause lipid peroxidation inhibit Dox-induced reduction of cardiac-specific gene [26] . ROS induces contractile failure and apoptosis in expression.
cardiac myocytes [27] . Pretreatment with catalase, ebselen, a glutathione peroxidase mimetic, or nitrone spin traps is Bcl-2 or Bcl-xl has been examined. In HL60 cells overreported to dramatically inhibit Dox-induced apoptosis expressing Bcl-2 protein, glutathione depletion-induced [28] . In addition to these direct antioxidants, the relation-ROS generation was significantly suppressed in association ship between the generation of ROS and the expression of with reduction of apoptotic cells [29] . On the other hand, Gottlieb et al. reported that overexpression of Bcl-xl prevented TNF-a-induced initial decrease in mitochondrial membrane potential and subsequent ROS production but did not prevent that induced by hydrogen peroxide [30] . They suggested that Bcl-xl controls membrane potential and subsequent ROS production in mitochondria rather than acting as a direct antioxidant. The ROS analyzed by FACScan includes not only hydrogen peroxide but also lipid peroxide, and generation of lipid peroxide was also not suppressed in BCL (data not shown). The ROS generations caused by 10 mM Dox or stimulating factor [31] . This finding suggests that Bax may SERCA2a in isolated cardiac myocytes [32] , and improve- function [33] . The reduced expression of cardiac-specific In summary, overexpression of Bcl-xl suppressed Dox- 
